Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    Report Prepared Matt Stenger

    Article

    Mechlorethamine gel for early stage mycosis fungoides-type CTCL

    Author:
    Edited Jame Abraham
    Report Prepared Matt Stenger
    • Read More

    Article

    Trametinib plus dabrafenib for unresectable or metastatic melanoma with BRAF V600E or V600K mutations

    Author:
    Edited Jame Abraham
    Report Prepared Matt Stenger
    • Read More

    Article

    Cobas HPV test for first-line screening for cervical cancer

    Author:
    Edited Jame Abraham
    Report Prepared Matt Stenger
    • Read More

    Article

    Obinutuzumab for previously untreated chronic lymphocytic leukemia

    Author:
    Edited Jame Abraham
    Report Prepared Matt Stenger

    Obinutuzumab was approved by the Food and Drug Administration in late 2013 for use in combination with chlorambucil for the treatment of patients...

    • Read More

    Article

    Pertuzumab in neoadjuvant treatment of HER2-positive early breast cancer

    Author:
    Edited Jame Abraham
    Report Prepared Matt Stenger

    Pertuzumab injection was granted accelerated approval by the US Food and Drug Administration last fall for use in combination with trastuzumab...

    • Read More

    Article

    Dabrafenib in advanced melanoma with BRAF V600E mutation

    Author:
    Edited Jame Abraham
    Report Prepared Matt Stenger

    Dabrafenib was recently approved by the US Food and Drug Administration for treatment of unresectable or metastatic melanoma with BRAF V600E...

    • Read More

    Article

    Afatinib in metastatic NSCLC with mutations

    Author:
    Edited Jame Abraham
    Report Prepared Matt Stenger

    In July 2013, afatinib was approved by the US Food and Drug Administration for first-line treatment of patients with metastatic non–small-cell...

    • Read More

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2024 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties
      • MDedge Home
      • Cardiology
      • Clinician Reviews
      • Dermatology
      • Emergency Medicine
      • Endocrinology/Diabetes
      • Family Medicine
      • Federal Practitioner
      • Gastroenterology
      • Hematology/Oncology
      • Infectious Disease
      • Internal Medicine
      • Neurology
      • Obstetrics And Gynecology
      • Pediatrics
      • Psychiatry
      • Pulmonology
      • Rheumatology
      • Surgery
    • MDedge Home
    • Cardiology
    • Clinician Reviews
    • Dermatology
    • Emergency Medicine
    • Endocrinology/Diabetes
    • Family Medicine
    • Federal Practitioner
    • Gastroenterology
    • Hematology/Oncology
    • Infectious Disease
    • Internal Medicine
    • Neurology
    • Obstetrics And Gynecology
    • Pediatrics
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Surgery